Molloy Niamh, Kilcoyne Imogen, Belcher Hannah, Wykes Til
Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Lancet Psychiatry. 2025 Feb;12(2):140-152. doi: 10.1016/S2215-0366(24)00376-6.
People with lived experience of mental health difficulties have highlighted that research outcomes do not capture issues they feel are important. This mismatch might affect the validity of trials, such that beneficial effects could be missed or results could be counted as a benefit when they are not. Co-development of patient-reported outcome measures ensures patient perspectives are captured adequately. To identify mental health outcome measures that meet a strict definition of being co-developed and to describe the methods and quantity of involvement at each pre-defined stage of measure co-development, we searched five electronic databases (MEDLINE, Web of Science, Scopus, PsycINFO, and Embase) for relevant papers, alongside a search of the non-peer reviewed literature and handsearching. The study was registered on PROSPERO (CRD42024520941). Retrieved papers were independently screened and quality was assessed following PRISMA guidelines. Extracted data were synthesised narratively. The search identified 23 mental health outcome measures from 34 papers. The most frequent types of involvement to co-develop outcomes were service-user researchers and lived experience groups as advisors undertaking activities such as leading qualitative exercises, but there were gaps. Many benefits were reported such as increased relevancy and acceptability of the measures. Based on these findings, recommendations for methods and a novel scale for judging quantity of involvement for co-development were identified, but challenges for co-development remain. The reviewed papers show that co-development is possible and could provide more relevant and meaningful outcomes for clinical practice and research.
有心理健康问题亲身经历的人强调,研究结果未能涵盖他们认为重要的问题。这种不匹配可能会影响试验的有效性,从而可能错过有益效果,或者在并非有益的情况下将结果视为有益。患者报告结局指标的共同开发可确保充分纳入患者的观点。为了确定符合严格共同开发定义的心理健康结局指标,并描述指标共同开发每个预定义阶段的参与方法和参与程度,我们在五个电子数据库(MEDLINE、Web of Science、Scopus、PsycINFO和Embase)中搜索了相关论文,并同时搜索了非同行评审文献并进行了手工检索。该研究已在PROSPERO(CRD42024520941)上注册。检索到的论文由独立筛选,并按照PRISMA指南评估质量。提取的数据进行了叙述性综合。该搜索从34篇论文中确定了23种心理健康结局指标。共同开发结局最常见的参与类型是服务使用者研究人员和有亲身经历的群体作为顾问,开展诸如主导定性研究之类的活动,但仍存在差距。报告了许多益处,例如指标的相关性和可接受性增加。基于这些发现,确定了共同开发方法的建议和一种用于判断参与程度的新量表,但共同开发仍面临挑战。经审查的论文表明,共同开发是可行的,并且可以为临床实践和研究提供更相关、更有意义的结果。